ADVANCED CELL TECHNOLOGY, INC. (ACTC) has 23 open-market insider trades by 3 insiders since 2010. The most active filer is Robert Lanza, Chief Scientific Officer.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Robert Lanza | Chief Scientific Officer | — | 12 | $2.9M | 2014-07-07 |
| Gary H. Rabin | CEO & CFO | — | 4 | $1.9M | 2013-01-10 |
| Erkki Ruoslahti | Dir | — | 7 | $403K | 2011-03-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert Lanza | Chief Scientific Officer | Sell | $120K | 2014-07-03 |
| Robert Lanza | Chief Scientific Officer | Sell | $80K | 2012-12-14 |
| Robert Lanza | Chief Scientific Officer | Sell | $160K | 2012-07-30 |
| Gary H. Rabin | CEO & CFO | Sell | $60K | 2012-06-11 |
| Robert Lanza | Chief Scientific Officer | Sell | $1.4M | 2012-01-23 |
| Robert Lanza | Chief Scientific Officer | Sell | $109K |
Companies that share insiders with ACTC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2011-09-28 |
| Gary H. Rabin | CEO & CFO | Sell | $150K | 2011-05-20 |
| Gary H. Rabin | CEO & CFO | Sell | $192K | 2011-03-15 |
| Erkki Ruoslahti | Director | Sell | $85K | 2011-03-04 |
| Erkki Ruoslahti | Director | Sell | $43K | 2011-03-03 |
| Erkki Ruoslahti | Director | Sell | $2K | 2011-03-01 |
| Erkki Ruoslahti | Director | Sell | $58K | 2011-02-25 |
| Erkki Ruoslahti | Director | Sell | $68K | 2011-02-17 |
| Erkki Ruoslahti | Director | Sell | $76K | 2011-02-14 |
| Erkki Ruoslahti | Director | Sell | $72K | 2011-02-10 |